Skip to main content

Table 5 Knowledge of paediatric (<2 years of age) quality-assured ACT dosing regimen among respondents from private for-profit outlets with quality-assured ACT in stock on the day of the survey at baseline (2010) and endline (2011)

From: Communicating the AMFm message: exploring the effect of communication and training interventions on private for-profit provider awareness and knowledge related to a multi-country anti-malarial subsidy intervention

Country

Baseline (%)

Endline (%)

Percentage point change (95% confidence interval)

Ghana

31.4

47.8

16.4 (8.7-24.0)

Kenya

67.4

60.6

−6.8 (−17.0-3.5)

Tanzania mainland

60.0

89.5

29.5 (11.7-47.1)

Zanzibar

15.4

48.7

33.3

Nigeria*

-

53.7

-

Niger

64.1

43.1

−21.0 (−34.3-7.8)

Madagascar*

-

41.6

-

Uganda

64.1

78.5

14.4 (3.3-25.4)

  1. Correct knowledge of paediatric quality-assured ACT dosing regimen was measured as respondents that correctly stated the number of tablets that should be taken at a time, the number of times the medicine should be taken per day, and the duration of the dose in number of days for child under 2 years (10 kg) for a specific product which they selected from the quality-assured ACT that they stocked.
  2. Nigeria baseline data collection was conducted in 2009. No confidence interval is shown for Zanzibar as a full census was carried out. Settings are roughly ordered by intensity of communication campaign and training intervention implementation (see Table 3).
  3. *These data are not available for Madagascar and Nigeria at baseline, as they were not collected in the ACTwatch survey.